Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Modeling neoplastic disease with spheroids and organoids
Cancer is a complex disease in which both genetic defects and microenvironmental
components contribute to the development, progression, and metastasization of disease …
components contribute to the development, progression, and metastasization of disease …
Zebrafish patient avatars in cancer biology and precision cancer therapy
In precision oncology, two major strategies are being pursued for predicting clinically
relevant tumour behaviours, such as treatment response and emergence of drug resistance …
relevant tumour behaviours, such as treatment response and emergence of drug resistance …
Zebrafish as a model system to study toxicology
YJ Dai, YF Jia, N Chen, WP Bian, QK Li… - Environmental …, 2014 - academic.oup.com
Monitoring and assessing the effects of contaminants in the aquatic eco‐environment is
critical in protecting human health and the environment. The zebrafish has been widely used …
critical in protecting human health and the environment. The zebrafish has been widely used …
Application of animal models in cancer research: Recent progress and future prospects
Z Li, W Zheng, H Wang, Y Cheng, Y Fang… - Cancer management …, 2021 - Taylor & Francis
Animal models refers to the animal experimental objects and related materials that can
simulate human body established in medical research. As the second-largest disease in …
simulate human body established in medical research. As the second-largest disease in …
Zebrafish as a preclinical in vivo screening model for nanomedicines
S Sieber, P Grossen, J Bussmann, F Campbell… - Advanced drug delivery …, 2019 - Elsevier
The interactions of nanomedicines with biological environments is heavily influenced by
their physicochemical properties. Formulation design and optimization are therefore key …
their physicochemical properties. Formulation design and optimization are therefore key …
Microfluidics: a new tool for modeling cancer–immune interactions
A Boussommier-Calleja, R Li, MB Chen, SC Wong… - Trends in cancer, 2016 - cell.com
In recognition of the enormous potential of immunotherapies against cancer, research into
the interactions between tumor and immune cells has accelerated, leading to the recent FDA …
the interactions between tumor and immune cells has accelerated, leading to the recent FDA …
From seeing to believing: labelling strategies for in vivo cell-tracking experiments
F Progatzky, MJ Dallman, C Lo Celso - Interface focus, 2013 - royalsocietypublishing.org
Intravital microscopy has become increasingly popular over the past few decades because it
provides high-resolution and real-time information about complex biological processes …
provides high-resolution and real-time information about complex biological processes …
[HTML][HTML] Patient-derived glioma models: from patients to dish to animals
CC da Hora, MW Schweiger, T Wurdinger, BA Tannous - Cells, 2019 - mdpi.com
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults
associated with a poor survival. Current standard of care consists of surgical resection …
associated with a poor survival. Current standard of care consists of surgical resection …
Imaging preclinical tumour models: improving translational power
M De Jong, J Essers, WM Van Weerden - Nature Reviews Cancer, 2014 - nature.com
Recent developments and improvements of multimodal imaging methods for use in animal
research have substantially strengthened the options of in vivo visualization of cancer …
research have substantially strengthened the options of in vivo visualization of cancer …
Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era
CJ Veinotte, G Dellaire… - Disease models & …, 2014 - journals.biologists.com
The current preclinical pipeline for drug discovery can be cumbersome and costly, which
limits the number of compounds that can effectively be transitioned to use as therapies …
limits the number of compounds that can effectively be transitioned to use as therapies …